Does the thought of eating certain foods make you anxious or uneasy?
Do they trigger swallowing difficulties, vomiting, or abdominal pain?
Then you may be able to take part in a new clinical research study.
Why is this study being conducted?
Usually, your immune system does a great job of keeping you healthy. But, sometimes, it reacts to things it shouldn’t. Like food. Eosinophilic esophagitis (EoE) is thought to be a type of allergy that is often caused by food. Because no medications have been approved to treat EoE, our study team is conducting a clinical research study to see if an investigational drug called budesonide oral suspension (BOS) can help.
Potential participants must be 11 to 55 years old and experience symptoms such as abdominal pain, swallowing difficulties or vomiting after eating certain foods.
What will happen if I take part?
Participation in the study lasts between 23 and 26 weeks. During the study treatment phase, two out of every three participants will receive BOS and one out of three will receive a placebo. Each participant will also visit a study clinic 6 times (around once per month) to allow the study team to monitor their health using various assessments. These assessments (along with any study-related drugs) will be provided at no cost.
What should I do now?
To learn more, please contact the study team. They’ll answer your questions and (if they believe you qualify) will arrange a screening visit. During this visit. the study team will discuss the study procedures with you and make sure that you (or your child) understand and agree (consent) to take part in the study.
Call Fellicia Grimes at: (719) 473-8330 x 8 or go to: www.orbitEoE.com